Dr. Maria Bernadette Doyle, MD

Dr. Doyle practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Doyle's NPI, 1700903820, was assigned on March 23, 2007. Dr. Doyle graduated from Royal College of Surgeons Ireland in 1996. Dr. Doyle holds Missouri license 2008024818.

Dr. Doyle's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Doyle also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Doyle's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Doyle to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doyle practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Doyle's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Doyle's licenses on file in 2 states: Missouri and Illinois.

Dmand AI lists colon removal, esophagus, stomach, or upper small intestine surgery, gallbladder removal, gastrointestinal obstruction and kidney transplant among the conditions Dr. Doyle treats.

CMS data shows 26 Medicare services from Dr. Doyle across 2 procedure codes in 2023, for 33 Medicare patients. Medicare paid $47,469 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Doyle in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doyle's median patient age at 68, with 52% women.

In 2024, Dr. Doyle wrote 188 Medicare Part D claims for 16 patients. 88% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $1,780 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Doyle for performance year 2024, reported as part of a group. Dr. Doyle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Doyle, published from 2009 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Liver Transplantation, Liver Neoplasms and Carcinoma, Hepatocellular. Dr. Doyle has published most often in J Am Coll Surg. Dr. Doyle's most frequent co-authors are Jason Reid Wellen, MD, Sakil S. Kulkarni, MD and Jeffrey A. Lowell, MD.

Dmand AI links Dr. Doyle to 2 clinical trials, 2 of them phase 1 studies. Conditions studied include Cholangiocarcinoma, Pancreatic Neoplasms and Carcinoma, Hepatocellular. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 75 general payments to Dr. Doyle from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 37% of the total. Novartis Pharmaceuticals Corporation paid the most, $25,599.

Dmand AI lists 2 awards for Dr. Doyle, most recently Regional Top Doctor in 2014.

Dr. Doyle graduated from Royal College of Surgeons Ireland in 1996.

Dr. Doyle is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.